GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Other Long-Term Liabilities

G.Barekat Pharm (XTEH:BRKT1) Other Long-Term Liabilities : IRR0 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Other Long-Term Liabilities?

G.Barekat Pharm's other long-term liabilities for the quarter that ended in Mar. 2017 was IRR0 Mil.


G.Barekat Pharm Other Long-Term Liabilities Historical Data

The historical data trend for G.Barekat Pharm's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Other Long-Term Liabilities Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Other Long-Term Liabilities
- -

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Other Long-Term Liabilities - -

G.Barekat Pharm Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


G.Barekat Pharm Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines